To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/879 - attachment 2 (PDF)

Found: Chronic fatigue syndrome 6 0 Decreased activity 1 0 Fatigue 128 0 Malaise 328 0 Death

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 7 (PDF)

Found: conditions Asthenia 3 0 Decreased activity 1 0 Fatigue 48 0 Malaise 9 0 Death

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: The cause of death was foetal death.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/937 - attachment 2 (PDF)

Found: Chronic fatigue syndrome 6 0 Decreased activity 1 0 Fatigue 128 0 Malaise 328 0 Death

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 3 (PDF)

Found: SARS -CoV-2 (severe acute respiratory syndrome coronavirus 2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/908 - attachment 2 (PDF)

Found: Coronavirus Vaccine - summary of Yellow Card reporting Data included: 09/12/2020 to 24/01

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/908 - attachment 3 (PDF)

Found: solution for injection COVID -19 Vaccine (ChAdOx1 S [recombinant]) Therapeutic area: Prevention of coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/945 - attachment 2 (PDF)

Found: Malaise 45 0 Complications associated with device NEC Injury associated with device 1 0 Death